ATE156016T1 - Glattmuskelrelaxierende arzneizubereitungen - Google Patents
Glattmuskelrelaxierende arzneizubereitungenInfo
- Publication number
- ATE156016T1 ATE156016T1 AT95115576T AT95115576T ATE156016T1 AT E156016 T1 ATE156016 T1 AT E156016T1 AT 95115576 T AT95115576 T AT 95115576T AT 95115576 T AT95115576 T AT 95115576T AT E156016 T1 ATE156016 T1 AT E156016T1
- Authority
- AT
- Austria
- Prior art keywords
- smooth muscle
- medicinal preparations
- muscle relaxing
- tryptophan
- serine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI942166A IT1271031B (it) | 1994-10-21 | 1994-10-21 | Composizioni farmaceutiche miorilassanti |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE156016T1 true ATE156016T1 (de) | 1997-08-15 |
Family
ID=11369756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95115576T ATE156016T1 (de) | 1994-10-21 | 1995-10-02 | Glattmuskelrelaxierende arzneizubereitungen |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0707853B1 (de) |
AT (1) | ATE156016T1 (de) |
CA (1) | CA2160938C (de) |
DE (2) | DE69500490T2 (de) |
DK (1) | DK0707853T3 (de) |
ES (1) | ES2088379T3 (de) |
GR (2) | GR960300039T1 (de) |
HK (1) | HK1001719A1 (de) |
IT (1) | IT1271031B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6911455B2 (en) | 1999-12-22 | 2005-06-28 | Smithkline Beecham Corporation | Methods for preparing pharmaceutical formulations |
AU779889B2 (en) * | 1999-12-22 | 2005-02-17 | Glaxo Group Limited | Methods for preparing pharmaceutical formulations |
DE102005030423A1 (de) * | 2005-06-30 | 2007-01-04 | Inresa Arzneimittel Gmbh | Neue Formulierung für Vecuroniumbromid |
CN101325947A (zh) * | 2005-12-08 | 2008-12-17 | 惠氏公司 | 脂质体组合物 |
EP2712611A1 (de) | 2012-09-27 | 2014-04-02 | B. Braun Melsungen AG | Stabilisierte wässrige Zusammensetzungen von neuromuskulären Blockiermitteln |
RU2594062C2 (ru) * | 2013-07-23 | 2016-08-10 | Закрытое акционерное общество "ЭкоФармПлюс" | Способ получения фармацевтического состава рокурония бромида в форме стабильного лиофилизата и фармацевтический состав, полученный этим способом |
CN107638391B (zh) * | 2016-07-22 | 2020-10-16 | 海南合瑞制药股份有限公司 | 一种注射用苯磺顺阿曲库铵组合物 |
CN108676052B (zh) * | 2018-08-16 | 2020-05-22 | 北京市新里程医药科技有限公司 | 一种罗库溴铵的制备方法及其药物组合物 |
CN111374942B (zh) * | 2018-12-30 | 2022-09-13 | 鲁南制药集团股份有限公司 | 一种甾体类肌松药注射液及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU675930B2 (en) * | 1992-02-18 | 1997-02-27 | Pharmos Corp. | Dry compositions for preparing submicron emulsions |
GB9302455D0 (en) * | 1993-02-08 | 1993-03-24 | Lab Inpharm N V | Process for preparing a pharmaceutical preparation having neuromuscular blocking activity |
-
1994
- 1994-10-21 IT ITMI942166A patent/IT1271031B/it active IP Right Grant
-
1995
- 1995-10-02 ES ES95115576T patent/ES2088379T3/es not_active Expired - Lifetime
- 1995-10-02 DE DE69500490T patent/DE69500490T2/de not_active Expired - Lifetime
- 1995-10-02 DE DE0707853T patent/DE707853T1/de active Pending
- 1995-10-02 AT AT95115576T patent/ATE156016T1/de active
- 1995-10-02 DK DK95115576.1T patent/DK0707853T3/da active
- 1995-10-02 EP EP95115576A patent/EP0707853B1/de not_active Expired - Lifetime
- 1995-10-19 CA CA002160938A patent/CA2160938C/en not_active Expired - Fee Related
-
1996
- 1996-08-31 GR GR960300039T patent/GR960300039T1/el unknown
-
1997
- 1997-09-17 GR GR970402416T patent/GR3024761T3/el unknown
-
1998
- 1998-01-27 HK HK98100704A patent/HK1001719A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE707853T1 (de) | 1996-12-12 |
DE69500490D1 (de) | 1997-09-04 |
HK1001719A1 (en) | 1998-07-03 |
EP0707853A1 (de) | 1996-04-24 |
CA2160938C (en) | 2008-07-15 |
GR3024761T3 (en) | 1997-12-31 |
ES2088379T3 (es) | 1997-10-16 |
ITMI942166A1 (it) | 1996-04-21 |
EP0707853B1 (de) | 1997-07-30 |
CA2160938A1 (en) | 1996-04-22 |
DE69500490T2 (de) | 1997-12-04 |
DK0707853T3 (da) | 1998-03-02 |
GR960300039T1 (en) | 1996-08-31 |
IT1271031B (it) | 1997-05-26 |
ITMI942166A0 (it) | 1994-10-21 |
ES2088379T1 (es) | 1996-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1255258B (it) | Composizioni farmaceutiche per l'applicazione per via nasale. | |
PT792287E (pt) | Analogos peptidicos da proteina basica da mielina humana | |
ATE306931T1 (de) | Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer | |
DE69614681D1 (de) | Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten | |
HK1039271A1 (en) | Method for prevention and/or cosmetic treatment ofskin stripe and use in dermatology. | |
TR199901132T2 (xx) | N-(aril/heteoaril) amino asit t�revleri, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler. | |
NO965012D0 (no) | Farmasöytisk preparat som omfatter glukagon | |
ATE73459T1 (de) | Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten. | |
HK1043475A1 (en) | Compositions and methods for treating infections using analogues of indolicidin | |
ID21956A (id) | Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut | |
BR9807076B1 (pt) | "uso de acetato de glatirâmero para a fabricação de medicamento para o tratamento de esclerose múltipla e composição farmacêutica" | |
ATE358684T1 (de) | Waessrige formulierung enthaltend tfpi und lösungsvermittlers | |
ATE156016T1 (de) | Glattmuskelrelaxierende arzneizubereitungen | |
MX9710252A (es) | Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento. | |
BR0211186A (pt) | peptìdeos e uso dos mesmos no escurecimento da pele | |
ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
MX9300558A (es) | Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene. | |
ATE201693T1 (de) | Hämoregulierende peptide | |
YU20050685A (sh) | Poboljšanje podnošljivosti farmaceutski delotvornih beta- amino kiselina | |
GEP20032975B (en) | Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition | |
FI942938A0 (fi) | Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan | |
SE9901773D0 (sv) | Förebyggande av karies i tänderna | |
EA200100477A1 (ru) | Фармацевтическая композиция тнр и эналаприла | |
IT1254191B (it) | Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina | |
BR0313432A (pt) | Uso terapêutico de aminoácidos bicìclicos ou tricìclicos fundidos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEIH | Change in the person of patent owner |